A valid and innovative 11-lipid metabolism gene signature model was constructed to predict the prognosis of CRC patients as an independent risk factors, including GGT5, ASAH1, HMGCL, CD36, DPM2, ACOX1, ANGPTL4, INSR, ADIPOQ, ALDH1A3, and MMP1. The gene discussed is DPM2; the disease is colorectal carcinoma.